Lumiradx Limited Warrant Stock Revenue
LumiraDx Limited Warrant fundamentals help investors to digest information that contributes to LumiraDx Limited's financial success or failures. It also enables traders to predict the movement of LumiraDx Stock. The fundamental analysis module provides a way to measure LumiraDx Limited's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LumiraDx Limited stock.
LumiraDx |
LumiraDx Limited Warrant Company Revenue Analysis
LumiraDx Limited's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current LumiraDx Limited Revenue | 254.48 M |
Most of LumiraDx Limited's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LumiraDx Limited Warrant is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, LumiraDx Limited Warrant reported 254.48 M of revenue. This is 96.66% lower than that of the Biotechnology sector and 87.16% lower than that of the Health Care industry. The revenue for all United States stocks is 97.3% higher than that of the company.
LumiraDx Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LumiraDx Limited's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LumiraDx Limited could also be used in its relative valuation, which is a method of valuing LumiraDx Limited by comparing valuation metrics of similar companies.LumiraDx Limited is currently under evaluation in revenue category among its peers.
LumiraDx Fundamentals
| Return On Asset | -0.28 | |||
| Profit Margin | (2.67) % | |||
| Operating Margin | (2.31) % | |||
| Number Of Shares Shorted | 101.28 K | |||
| Revenue | 254.48 M | |||
| EBITDA | (273.54 M) | |||
| Net Income | (449.19 M) | |||
| Total Debt | 401.25 M | |||
| Book Value Per Share | (4.56) X | |||
| Cash Flow From Operations | (162.11 M) | |||
| Earnings Per Share | (2.93) X | |||
| Number Of Employees | 1.21 K | |||
| Beta | 1.71 | |||
| Total Asset | 441.01 M | |||
| Retained Earnings | (1.09 B) | |||
| Working Capital | 179.82 M | |||
| Z Score | -4.44 | |||
| Net Asset | 441.01 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in LumiraDx Stock
If you are still planning to invest in LumiraDx Limited Warrant check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LumiraDx Limited's history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |